Showing results (1291-1300 of 1,332) with videos related to

Sort By:
Pageof 134
Food Science & Nutrition|April 8, 2026
Salidroside Ameliorates Polycystic Ovary Syndrome in Mice by Regulating the AKT/NF-κB/NLRP3-HAS2 AxisJing-Hang Li, Shu-Ming Shi, Li-Ying Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domainJ Scott Sawyer, Douglas W Beight, Karen S Britt, et al.
Nano-Micro Letters|December 19, 2025
Gas-Phase Construction of Compact Capping Layers for High-Performance Halide Perovskite X-Ray DetectorsBin Zhang, Chuanyun Hao, Shoufeng Zhang, et al.
BMJ (Clinical Research Ed.)|October 15, 2025
Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysisLei Yan, Dijun Li, Dan Xing, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domainJ Scott Sawyer, Bryan D Anderson, Douglas W Beight, et al.
Clinical and Translational Medicine|June 18, 2024
KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenomaQin Xu, Ting La, Kaihong Ye, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|October 30, 2023
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial EmulationGeorge N Ioannou, Kristin Berry, Nallakkandi Rajeevan, et al.
Journal of Medicinal Chemistry|March 5, 2008
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agentHong-Yu Li, William T McMillen, Charles R Heap, et al.
Pageof 134